Lv51
1010 积分 2021-03-16 加入
Development and Validation of Machine Learning-based Model for Predicting Early Recurrence for Patients with HBV-associated Hepatocellular Carcinoma After Curative Hepatectomy
1小时前
待确认
Drug allergy history predicts early progression-free survival benefit from PD-(L)1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study
13天前
已完结
Polypoid Gastric Metastasis as Initial Finding of Prostate Cancer: A Rare Case Report
2个月前
已完结
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
2个月前
已完结
Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma
2个月前
已完结
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
3个月前
已完结
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
3个月前
已完结
Hepatocellular carcinoma
4个月前
已完结
Advances in Locoregional and Systemic Treatments for HCC
5个月前
已完结
Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians
5个月前
已完结
皖公网安备34019202002308
